Tudor Investment Corp’s Soleno Therapeutics SLNO Stock Holding History

Tudor Investment Corp’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-56,118	Closed	-$1.88M	–	4214
2026 Q1	$1.88M	Buy	+56,118	New	+$2.2M	﹤0.01%	1897
2024 Q4	–	Sell	-41,888	Closed	-$2.11M	–	3467
2024 Q3	$2.11M	Buy	41,888 +24,186	+137%	+$1.16M	0.01%	1166
2024 Q2	$722K	Buy	17,702 +1,508	+9%	+$63.9K	﹤0.01%	1632
2024 Q1	$693K	Buy	+16,194	New	+$733K	﹤0.01%	1503

Tudor Investment Corp's SLNO Position: Q2 2026 in Review

Tudor Investment Corp sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 56,118 shares — an estimated $1.88M sold.

Tudor Investment Corp first reported a position in SLNO in Q1 2024 and held it in 4 quarters. The position peaked at $2.11M in Q3 2024. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Tudor Investment Corp reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Tudor Investment Corp sold 56,118 Soleno Therapeutics shares in Q2 2026, an estimated $1.88M.
Tudor Investment Corp first reported a position in Soleno Therapeutics in Q1 2024 and held it in 4 quarters.
Tudor Investment Corp's Soleno Therapeutics position peaked at $2.11M in Q3 2024.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.